Advanced search
Publication Cover
Expert Opinion on Investigational Drugs Volume 19, 2010 - Issue 6
Submit an article Journal homepage
346
Views
11
CrossRef citations to date
0
Altmetric
Drug Evaluations

BIBF 1120 for the treatment of non-small cell lung cancer

Martin Reck Hospital Grosshansdorf, Department of Thoracic Oncology, Grosshansdorf, Germany +49 4102 601 188; +49 4102 691 317; [email protected]
Pages 789-794 | Published online: 13 May 2010

Citations (11)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Fabio Perrotta, Vittorio Chino, Valentino Allocca, Vito D’Agnano, Chandra Bortolotto, Andrea Bianco, Angelo Guido Corsico & Giulia Maria Stella. (2022) Idiopathic pulmonary fibrosis and lung cancer: targeting the complexity of the pharmacological interconnection. Expert Review of Respiratory Medicine 16:10, pages 1043-1055.
Read now
David Bruce & Peng H Tan. (2011) Blocking the interaction of vascular endothelial growth factor receptors with their ligands and their effector signaling as a novel therapeutic target for cancer: time for a new look?. Expert Opinion on Investigational Drugs 20:10, pages 1413-1434.
Read now
M Roshni Ray, David Jablons & Biao He. (2010) Lung cancer therapeutics that target signaling pathways: an update. Expert Review of Respiratory Medicine 4:5, pages 631-645.
Read now

Articles from other publishers (8)

Rakesh P. Dhavale, Rushikesh P. Dhavale, Manish S. Bhatia, Sagar U. Jadhav, Maruti J. Dhanavade, Sagar S. Barale, Sachin Pathak, Vinayak G. Parale & Kailas D. Sonawane. (2023) Exploring anticancer potential of nintedanib conjugated magnetic nanoparticles: In-vitro and in-silico studies. Journal of Drug Delivery Science and Technology 81, pages 104213.
Crossref
Argyris Tzouvelekis, Georgia Gomatou, Evangelos Bouros, Rodoula Trigidou, Vasilios Tzilas & Demosthenes Bouros. (2019) Common Pathogenic Mechanisms Between Idiopathic Pulmonary Fibrosis and Lung Cancer. Chest 156:2, pages 383-391.
Crossref
Yujie Zhao & Alex A. Adjei. (2015) Targeting Angiogenesis in Cancer Therapy: Moving Beyond Vascular Endothelial Growth Factor. The Oncologist 20:6, pages 660-673.
Crossref
Jaume Capdevila, Alfredo Carrato, Josep Tabernero & Enrique Grande. (2014) What could Nintedanib (BIBF 1120), a triple inhibitor of VEGFR, PDGFR, and FGFR, add to the current treatment options for patients with metastatic colorectal cancer?. Critical Reviews in Oncology/Hematology 92:2, pages 83-106.
Crossref
Athanasios G. Pallis & Konstantinos N. Syrigos. (2013) Targeting tumor neovasculature in non-small-cell lung cancer. Critical Reviews in Oncology/Hematology 86:2, pages 130-142.
Crossref
M. Majem & C. Pallarès. (2013) An update on molecularly targeted therapies in second- and third-line treatment in non-small cell lung cancer: focus on EGFR inhibitors and anti-angiogenic agents. Clinical and Translational Oncology 15:5, pages 343-357.
Crossref
D. Nathan Kim, Taek-Keun Nam, Kevin S. Choe & Hak Choy. (2012) Personalized Combined Modality Therapy for Locally Advanced Non-small Cell Lung Cancer. Cancer Research and Treatment 44:2, pages 74-84.
Crossref
Qing-feng Xiang, Fang Wang, Xiao-dong Su, Yong-ju Liang, Li-sheng Zheng, Yan-jun Mi, Wei-qiang Chen & Li-wu Fu. (2011) Effect of BIBF 1120 on reversal of ABCB1-mediated multidrug resistance. Cellular Oncology 34:1, pages 33-44.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.